Your browser doesn't support javascript.
loading
Long-lasting successful dissemination of resistance to oxazolidinones in MDR Staphylococcus epidermidis clinical isolates in a tertiary care hospital in France.
Dortet, Laurent; Glaser, Philippe; Kassis-Chikhani, Najiby; Girlich, Delphine; Ichai, Philippe; Boudon, Marc; Samuel, Didier; Creton, Elodie; Imanci, Dilek; Bonnin, Rémy; Fortineau, Nicolas; Naas, Thierry.
Afiliação
  • Dortet L; Department of Bacteriology-Parasitology-Hygiene, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • Glaser P; EA7361 'Structure, dynamic, function and expression of broad spectrum ß-lactamases', Paris-Sud University, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France.
  • Kassis-Chikhani N; Associated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France.
  • Girlich D; Joint Research Unit EERA 'Evolution and Ecology of Resistance to Antibiotics', Institut Pasteur-APHP-University Paris Sud, Paris, France.
  • Ichai P; Joint Research Unit EERA 'Evolution and Ecology of Resistance to Antibiotics', Institut Pasteur-APHP-University Paris Sud, Paris, France.
  • Boudon M; UMR 3525, CNRS, 75015 Paris, France.
  • Samuel D; Department of Hygiene, Paul Brousse Hospital, Assistance Publique - Hôpitaux de Paris, Villejuif, France.
  • Creton E; EA7361 'Structure, dynamic, function and expression of broad spectrum ß-lactamases', Paris-Sud University, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France.
  • Imanci D; Associated French National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France.
  • Bonnin R; Joint Research Unit EERA 'Evolution and Ecology of Resistance to Antibiotics', Institut Pasteur-APHP-University Paris Sud, Paris, France.
  • Fortineau N; Intensive Care Unit, Hepatobiliary Center, Paul Brousse Hospital, Assistance Publique - Hôpitaux de Paris, Villejuif, France.
  • Naas T; Intensive Care Unit, Hepatobiliary Center, Paul Brousse Hospital, Assistance Publique - Hôpitaux de Paris, Villejuif, France.
J Antimicrob Chemother ; 73(1): 41-51, 2018 Jan 01.
Article em En | MEDLINE | ID: mdl-29092052
ABSTRACT

OBJECTIVES:

Patient- and procedure-related changes in modern medicine have turned CoNS into one of the major nosocomial pathogens. Treatments of CoNS infections are challenging owing to the large proportion of MDR strains and oxazolidinones often remain the last active antimicrobial molecules. Here, we have investigated a long-lasting outbreak (2010-13) due to methicillin- and linezolid-resistant (LR) CoNS (n = 168), involving 72 carriers and 49 infected patients.

METHODS:

Antimicrobial susceptibilities were tested by the disc diffusion method and MICs were determined by broth microdilution or Etest. The clonal relationship of LR Staphylococcus epidermidis (LRSE) was first determined using a semi-automated repetitive element palindromic PCR (rep-PCR) method. Then, WGS was performed on all cfr-positive LRSE (n = 30) and LRSE isolates representative of each rep-PCR-defined clone (n = 17). Self-transferability of cfr-carrying plasmids was analysed by filter-mating experiments.

RESULTS:

This outbreak was caused by the dissemination of three clones (ST2, ST5 and ST22) of LRSE. In these clones, linezolid resistance was caused by (i) mutations in the chromosome-located genes encoding the 23S RNA and L3 and L4 ribosomal proteins, but also by (ii) the dissemination of two different self-conjugative plasmids carrying the cfr gene encoding a 23S RNA methylase. By monitoring linezolid prescriptions in two neighbouring hospitals, we highlighted that the spread of LR-CoNS was strongly associated with linezolid use.

CONCLUSIONS:

Physicians should be aware that plasmid-encoded linezolid resistance has started to disseminate among CoNS and that rational use of oxazolidinones is critical to preserve these molecules as efficient treatment options for MDR Gram-positive pathogens.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus epidermidis / Farmacorresistência Bacteriana Múltipla / Linezolida / Antibacterianos Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Estafilocócicas / Staphylococcus epidermidis / Farmacorresistência Bacteriana Múltipla / Linezolida / Antibacterianos Limite: Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article